Position in VYGR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$365,460
-$690,895 QoQ
Shares Held
94,679
-64.8% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. VYGR ranks #300 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in VYGR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $365,460 | 94,679 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,056,355 | 268,793 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,209,376 | 473,100 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,416,735 | 455,542 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,203,049 | 355,932 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,130,086 | 199,310 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $141,938 | 24,263 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $462,671 | 58,492 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $970,884 | 104,284 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $275,935 | 32,694 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $109,731 | 14,159 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $295,833 | 25,837 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $38,950 | 5,052 | Shares | Sole | 2023-05-12 | |
| 2022-09-30 | $16,001 | 2,703 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,247 | 211 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $31,432 | 4,125 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,029 | 6,653 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $495,810 | 188,521 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $603,388 | 146,099 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $671,104 | 142,485 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $221,321 | 30,954 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $17,818 | 1,670 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $69,282 | 5,490 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $10,980 | 1,200 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||